Senores Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, for quarter ended March 31, 2025.
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals Limited has submitted a compliance certificate to the stock exchange as required under the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2025. This is a routine regulatory filing that companies are required to submit periodically to confirm adherence to depositary-related norms, such as reconciliation of shareholdings between physical and electronic (demat) forms. No financial figures, business developments, or strategic updates are mentioned in this disclosure. The filing is purely procedural and reflects ongoing compliance with securities market regulations.
This is a routine compliance filing with no material impact on the company's business, financials, or shareholder value. Investors should treat it as a neutral, administrative disclosure.